Key result
Minimally invasive video-assisted TVR and pacemaker lead ablation maintains asymptomatic normal valve function at 22 months.
Case Report (n=1)
Minimally invasive video-assisted tricuspid valve replacement is a feasible approach for treating pacemaker lead endocarditis with tricuspid regurgitation.
Answers are grounded in this paper and cite their sources.
May support feasibility in select pacemaker lead endocarditis cases; leaves open need for prospective data before wider adoption.
A patient presenting with a pacemaker lead infection and tricuspid regurgitation underwent a minimally invasive video-assisted tricuspid valve replacement. The valve was approached through a right anterior mini thoracotomy. Under thoracoscopic vision and peripheral cardiopulmonary bypass, a catheter was placed on the ascending aorta for antegrade cardioplegia delivery. A transthoracic aortic cross-clamp was introduced through the third right intercostal space. Tricuspid valve replacement added to the pacemaker leads ablation was exclusively performed under thoracoscopic vision, providing an excellent video-image in this reduced operative field. After 22 months of follow up, the patient is asymptomatic, the echocardiography showing a normally functioning valve.
No takes yet. Share an insight, caveat, or question.
Robin et al. (1999) conducted a case report in Pacemaker lead infection and tricuspid regurgitation (n=1). Minimally invasive video-assisted tricuspid valve replacement and pacemaker leads ablation was evaluated on Clinical status and echocardiographic valve function at follow-up. Minimally invasive video-assisted tricuspid valve replacement and pacemaker lead ablation resulted in the patient being asymptomatic with a normally functioning valve at 22 months of follow-up.
Synapse has enriched 10 related papers. Consider them for comparative context: